E-drug: Geneva meeting on global R&D framework, 29 April 2003
-------------------------------------------------------------------------
International Meeting on a global framework for supporting health
research and development (R&D) in areas of market and public
policy failure. Geneva, 29 April 2003.
In May the World Health Assembly will discuss "Intellectual
Property Rights, Innovation and Public Health". Running up to the
WHA, M�decins sans Fronti�res (MSF), Consumer Project on
Technology (CPTECH), OXFAM, Health Action International (HAI)
and Third World Network (TWN) organize a one day meeting in
Geneva on April 29, 2003. The key theme of the meeting is the
need for a global approach for ensuring research and development
(R&D) in areas of market and public policy failure. The purpose of
the meeting will be to review different frameworks for ensuring
R&D that meet real health needs in areas where private incentives
are not sufficient or not appropriate. Speakers at the meeting will
be asked to address the following themes:
- The international essential research agenda
- R&D for AIDS drugs to help scale up the AIDS treatment
- Drugs for Neglected Diseases and Vaccine development
- Public domain databases of gene sequences or other important
data
- Research for appropriate technologies, such as low cost
diagnostic tests and devices
- Technology transfer for developing countries
- Transparency of investment flow, and its relationship to R&D
- Existing global mechanisms for health R&D
The meeting will bring together officials from national governments
and International organizations, academia, research institutes, public
health and development NGOs, private industry and others to
discuss possible mechanisms for global cooperation in raising levels
of R&D, and increasing the transparency of such efforts, as well as
fulfilling global obligations to facilitate technology transfer. The
meeting will discuss possible legal frameworks to enhancing global
cooperation on funding such R&D efforts, including for example
models for international convention on R&D. There is no specific
grant for this meeting, and most participants will be expected to
cover their own travel expenses.
Venue:
The meeting will take place at:
The International Conference Centre of Geneva (CICG), 15 rue de
Varemb�, 1211 Gen�ve 20, Switzerland from 9.00h. � 18.00h.
Participation is limited. If you would like to reserve a place in the
meeting please contact: Ms Joy Spencer in Washington at
joy.spencer@cptech.org (+1.202.387.8030, fax 1.202.234.5176)
or Ms Mai Do in Paris at: mdo@paris.msf.org (+ 33 1 4021 2825)
You can contact Ms Spencer or Ms Do for additional information
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug